top of page

Board Appointments

ZAGENO, Chairman

ZAGENO is a feature-rich digital marketplace designed to facilitate intelligent, streamlined purchasing decisions for scientist in bio-pharma R+D.  ZAGENO offers independent and relevant bench knowledge. Scientists identify and digitally purchase critical products for their experiments more reliably, faster, and cheaper - thus driving down the time & cost to scientific breakthrough.

Aileron Th​erapeutics, Director

Aileron, a clinical stage biotechnology company, intends to advance a pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, including LTI-03 for idiopathic pulmonary fibrosis (IPF) and LTI-01, for loculated pleural effusion (LPE).

Aileron Therapeutics Logo

Javara, Inc., Board Member

ShapeTX, Board Member

 

Network for Excellence in Health Innovation, Director

Javara provides clinical research access for patients at the point of care by embedding staff and infrastructure into large healthcare organizations, resulting in greater access to cutting-edge innovations while expediting FDA approval through reliable, robust data.

Shape Therapeutics was founded with the mission to make programmable RNA medicines available for everyone. A dynamic team of scientists, engineers, and problem solvers are dedicated and passionate about making cures a reality. Through diversity of thought, scientific knowledge, and resolute focus, they are merging cutting-edge science with drug development expertise to change patients’ lives.

Founded in 1811, McLean is a national leader in psychiatric care, research, and education and is the largest psychiatric teaching hospital of Harvard Medical School. McLean Hospital is part of the Mass General Brigham (MGB) healthcare system in Boston. Staff, faculty, volunteers, and supporters are dedicated to improving the lives of individuals and families affected by mental illness. 

NEHI is a national nonprofit, nonpartisan organization composed of stakeholders from across all key sectors of health and health care. Its mission is to advance innovations that improve health, enhance the quality of health care, and achieve greater value for the money spent. NEHI consults with its broad membership, and conducts independent, objective research and convenings, to accelerate these innovations and bring about changes within health care and in public policy.

Previous Board Appointments

​

  • Chairman of the Board, PAREXEL International Corp. Biopharma Services / Clinical Research.  

  • Chairman of the Board, The Association of Clinical Research Organizations (ACRO) in 2005 & 2013 

  • Board Member, IRIS S.A., Belgium. Now a division of Canon, Inc. Optical Character Recognition Technology. 

  • Board Member, Epidauros Biotechnologie AG, Germany. Now a division of Danaher Corp. Pharmacogenetic and Genotyping Research. 

  • Board Member, Tektagen, Inc. Biosafety and Analytical Testing. Now a division of Charles River Laboratories International, Inc. 

  • Board Member, Next Generation Acquisition Corp. SPAC. Merged with Xos, Inc.

  • Board Member, Next Generation Acquisition Corp. II. SPAC. Merged with Virgin Orbit.

  • Board Member, Biomedical Science Careers Program (BSCP). Inner-city Youth Support for the Pursuit of Biomedical Science Careers.​

bottom of page